Cognitive Health Research on Musical Arts

计划入组 81 人 · 首次发布于 2019 年 10 月 24 日

Pharmacotherapy and Psychotherapy for MDD After Remission on Psychology and Neuroimaging

计划入组 200 人 · 首次发布于 2013 年 4 月 15 日

Treatment of Burning Mouth Syndrome With Integration of Traditional Chinese Medicine and Western Medicine

计划入组 80 人 · 首次发布于 2019 年 12 月 6 日

PCSK9-targeted epigenetic editor (Chroma Medicine)

CHR-3620

aurora kinase inhibitors (Chroma Therapeutics)

Chroma Therapeutics Ltd.

United Kingdom

Editas Medicine

United States

Clearmind Medicine

Kymera Therapeutics Appoints Noah Goodman as Chief Business Officer to Advance Protein Degradation Platform

Sofinnova Partners Secures €1.2 Billion to Fuel Next Wave of Biotech Innovation

Breakthrough Year for Liver Disease Treatments: FDA Approvals and Clinical Advances Mark 2024